Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Hazra

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|February 18, 2015
Early viral suppression improves neurocognitive outcomes in HIV-infected childrenClaudia S Crowell, Yanling Huo, Katherine Tassiopoulos, et al.
Journal of the Pediatric Infectious Diseases Society|February 17, 2017
Prevalence and Associated Characteristics of HIV-Infected Children in Latin America Who Know Their HIV StatusSonia Lee, George K Siberry, Jorge O Alarcón, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 16, 2014
Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countriesManuel Koller, Kunjal Patel, Benjamin H Chi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2015
Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral TherapyGayatri Mirani, Paige L Williams, Miriam Chernoff, et al.
Eclinicalmedicine|January 30, 2020
Early antiretroviral treatment of infants to attain HIV remissionLouise Kuhn, Renate Strehlau, Stephanie Shiau, et al.
AIDS (London, England)|December 28, 2017
Changes in insulin sensitivity over time and associated factors in HIV-infected adolescentsMitchell E Geffner, Kunjal Patel, Denise L Jacobson, et al.
Journal of the Pediatric Infectious Diseases Society|April 6, 2019
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 StudyRolando M Viani, Theodore Ruel, Carmelita Alvero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapyGeorge K Siberry, D Robert Harris, Ricardo Hugo Oliveira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2020
Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110)Diana F Clarke, Edward P Acosta, Mae Cababasay, et al.
American Journal of Epidemiology|April 12, 2012
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothersPaige L Williams, George R Seage, Russell B Van Dyke, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|February 18, 2015
Early viral suppression improves neurocognitive outcomes in HIV-infected childrenClaudia S Crowell, Yanling Huo, Katherine Tassiopoulos, et al.
Journal of the Pediatric Infectious Diseases Society|February 17, 2017
Prevalence and Associated Characteristics of HIV-Infected Children in Latin America Who Know Their HIV StatusSonia Lee, George K Siberry, Jorge O Alarcón, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 16, 2014
Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countriesManuel Koller, Kunjal Patel, Benjamin H Chi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2015
Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral TherapyGayatri Mirani, Paige L Williams, Miriam Chernoff, et al.
Eclinicalmedicine|January 30, 2020
Early antiretroviral treatment of infants to attain HIV remissionLouise Kuhn, Renate Strehlau, Stephanie Shiau, et al.
AIDS (London, England)|December 28, 2017
Changes in insulin sensitivity over time and associated factors in HIV-infected adolescentsMitchell E Geffner, Kunjal Patel, Denise L Jacobson, et al.
Journal of the Pediatric Infectious Diseases Society|April 6, 2019
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 StudyRolando M Viani, Theodore Ruel, Carmelita Alvero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapyGeorge K Siberry, D Robert Harris, Ricardo Hugo Oliveira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2020
Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110)Diana F Clarke, Edward P Acosta, Mae Cababasay, et al.
American Journal of Epidemiology|April 12, 2012
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothersPaige L Williams, George R Seage, Russell B Van Dyke, et al.
Pageof 15